A part of the patients diagnosed with CCA can have altered laboratory findings suggestive for hypercalcemia of malignancy (hypercalcemia associated with hypophosphatemia, low parathyroid hormone and vitamin D levels) [22,23]. The gene discussed is PTH; the disease is hypophosphatemia.